Ya-zhen Wu
Biographic Data
| ID | 10000462 |
|---|---|
| NAME | Ya-zhen Wu |
| GIVEN NAMES | Ya-zhen |
| FAMILY NAME | Wu |
| SIGNATURE | WU Y |
| AFFILIATIONS | Department of Ophthalmology, Xi'an People's Hospital (Xi'an Fourth Hospital) |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Paradox of atropine in myopia control
The global surge in myopia prevalence, particularly the rising incidence of high myopia and its associated blinding complications—including myopic maculopathy, retinal detachment, and glaucoma—has transformed this condition into a pressing public health priority. Atropine, the most extensively studied pharmacological intervention for myopia control, now stands at a critical crossroads. The shift from high-concentration to low-concentration formul…
No prominent works on this page.
Paradox of atropine in myopia control
The global surge in myopia prevalence, particularly the rising incidence of high myopia and its associated blinding complications—including myopic maculopathy, retinal detachment, and glaucoma—has transformed this condition into a pressing public health priority. Atropine, the most extensively studied pharmacological intervention for myopia control, now stands at a critical crossroads. The shift from high-concentration to low-concentration formul…
Atropine (1 work) · Blinding (1 work) · Corneal surgery and disorders (1 work) · Ophthalmology and Visual Impairment Studies (1 work) · Psychological intervention (1 work) · Refractive error (1 work) · Retinopathy of Prematurity Studies (1 work)